Currently out of the existing stock ratings of Michael Sarcone, 5 are a HOLD (33.33%), 10 are a BUY (66.67%).

Michael Sarcone

Work Performance Price Targets & Ratings Chart

Analyst Michael Sarcone, currently employed at JEFFERIES, carries an average stock price target met ratio of 80% that have a potential upside of 15.28% achieved within 128 days.

Michael Sarcone’s has documented 29 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSP, Inspire Medical Systems at 12-Feb-2026.

Wall Street Analyst Michael Sarcone

Analyst best performing recommendations are on EDAP (EDAP TMS SA).
The best stock recommendation documented was for EDAP (EDAP TMS SA) at 4/4/2025. The price target of $2 was fulfilled within 21 days with a profit of $0.39 (24.22%) receiving and performance score of 11.54.

Average potential price target upside

AXGN Axogen EDAP EDAP TMS SA INSP Inspire Medical Systems PRCT Procept Biorobotics Corp XRAY Dentsply Sirona

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Mar-2025

$55

$4.6 (9.13%)

$50

Buy Since 30-Sep-2025

$53

$2.6 (5.16%)

$50

Buy Since 17-Mar-2025

$50

$5.07 (11.28%)

$40

Buy Since 07-Dec-2023

$40

$-4.93 (-10.97%)

$37

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Michael Sarcone?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?